miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5

被引：45

作者：

Zhou, Wenhui ^{[1
,2
,3
,4
,5
]}

Song, Fangfang ^{[4
,5
,6
,7
]}

Wu, Qiuju ^{[4
,5
,6
,7
]}

Liu, Rong ^{[4
,5
]}

Wang, Lulu ^{[2
,3
]}

Liu, Cuicui ^{[2
,3
]}

Peng, You ^{[2
,3
]}

Mao, Shuqin ^{[8
]}

Feng, Jing ^{[1
,2
,3
]}

Chen, Ceshi ^{[4
,5
]}

机构：

[1] Southern Med Univ, Clin Coll 3, Guangzhou, Guangdong, Peoples R China

[2] Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China

[3] Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China

[4] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China

[5] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China

[6] Jinzhou Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China

[7] Jinzhou Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China

[8] Hubei Univ Med, Affiliated Taihe Hosp, Shiyan, Hubei Province, Peoples R China

来源：

PLOS ONE | 2017年 / 12卷 / 04期

关键词：

PANCREATIC DUCTAL ADENOCARCINOMA; TRANSCRIPTION FACTOR; PROTEASOME DEGRADATION; PROLIFERATION; SURVIVAL; MICRORNA-217; CARCINOMA; EXPRESSION; KINASE;

D O I：

10.1371/journal.pone.0176395

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Triple negative breast cancer (TNBC) is one of the most aggressive breast cancers without effective targeted therapies. Numerous studies have implied that KLF5 plays an important roles in TNBC. How is KLF5 regulated by microRNAs has not been well studied. Here, we demonstrated that miR-217 down-regulates the expression of KLF5 and KLF5's downstream target gene FGF-BP and Cyclin D1 in TNBC cell lines HCC1806 and HCC1937. Consequently, miR-217 suppresses TNBC cell growth, migration, and invasion. MiR-217 suppresses TNBC, at least partially, through down-regulating the KLF5 expression. These results suggest that the miR-217-KLF5 axis might serve as a potential target for treatment of TNBC.

引用

页数：12

共 50 条

[41] UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5
Li, Juan
Liang, Yu
Zhou, Shijie
Chen, Jie
Wu, Chihua
BREAST CANCER RESEARCH, 2024, 26 (01)
[42] miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Kong, Peng
Chen, Lie
Yu, Muxin
Tao, Jing
Liu, Jiawei
Wang, Yue
Pan, Hong
Zhou, Wenbin
Wang, Shui
CELL DEATH & DISEASE, 2018, 9
[43] miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Peng Kong
Lie Chen
Muxin Yu
Jing Tao
Jiawei Liu
Yue Wang
Hong Pan
Wenbin Zhou
Shui Wang
Cell Death & Disease, 9
[44] MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
Cheng Wang
Cheng Xu
Ruijie Niu
Guangfu Hu
Zhangyuan Gu
Zhigang Zhuang
BMC Cancer, 19
[45] MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
Wang, Cheng
Xu, Cheng
Niu, Ruijie
Hu, Guangfu
Gu, Zhangyuan
Zhuang, Zhigang
BMC CANCER, 2019, 19 (1)
[46] WWOX suppresses KLF5 expression and breast cancer cell growth
Fei Ge
Wenlin Chen
Runxiang Yang
Zhongmei Zhou
Nanshan Chang
Ceshi Chen
Tianning Zou
Rong Liu
Jing Tan
Guosheng Ren
ChineseJournalofCancerResearch, 2014, 26 (05) : 511 - 516
[47] WWOX suppresses KLF5 expression and breast cancer cell growth
Ge, Fei
Chen, Wenlin
Yang, Runxiang
Zhou, Zhongmei
Chang, Nanshan
Chen, Ceshi
Zou, Tianning
Liu, Rong
Tan, Jing
Ren, Guosheng
CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (05) : 511 - 516
[48] SPDEF targets EMT pathway to inhibit cell migration and invasion in triple-negative breast cancer
Yousefi, Hassan
Vatanmakanian, Mousa
Koul, Sweaty
Okpechi, Samuel
Alahari, Suresh
Koul, Hari
FASEB JOURNAL, 2021, 35
[49] Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer
Guo, Yaxun
Li, Yuzhan
Zhou, Zhongmei
Hou, Lei
Liu, Wenjing
Ren, Wenlong
Mi, Dazhao
Sun, Jian
Dai, Xueqin
Wu, Yingying
Cheng, Zhuo
Wu, Tingyue
Luo, Qianmei
Tian, Cong
Li, Fubing
Yu, Zhigang
Chen, Yihua
Chen, Ceshi
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
[50] MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer
Guo, S. -J.
Zeng, H. -X.
Huang, P.
Wang, S.
Xie, C. -H.
Li, S. -J.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) : 6379 - 6385

← 1 2 3 4 5 →